Welcome to LookChem.com Sign In|Join Free

CAS

  • or

57769-01-4

Butanoic acid, 4-hydroxy-, monopotassium salt is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

57769-01-4 Suppliers

This product is a nationally controlled contraband or patented product, and the Lookchem platform doesn't provide relevant sales information.
  • 57769-01-4 Structure

  • Basic information

    1. Product Name: Butanoic acid, 4-hydroxy-, monopotassium salt
    2. Synonyms:
    3. CAS NO:57769-01-4
    4. Molecular Formula: C4H8O3.K
    5. Molecular Weight: 142.196
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 57769-01-4.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Butanoic acid, 4-hydroxy-, monopotassium salt(CAS DataBase Reference)
    10. NIST Chemistry Reference: Butanoic acid, 4-hydroxy-, monopotassium salt(57769-01-4)
    11. EPA Substance Registry System: Butanoic acid, 4-hydroxy-, monopotassium salt(57769-01-4)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 57769-01-4(Hazardous Substances Data)

57769-01-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 57769-01-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,7,6 and 9 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 57769-01:
(7*5)+(6*7)+(5*7)+(4*6)+(3*9)+(2*0)+(1*1)=164
164 % 10 = 4
So 57769-01-4 is a valid CAS Registry Number.

57769-01-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name potassium salt of gamma-hydroxy butyric acid

1.2 Other means of identification

Product number -
Other names potassium 4-hydroxybutyrate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:57769-01-4 SDS

57769-01-4Relevant articles and documents

Kinetic and mechanistic studies on the oxidation of pyrrolidine by bis(hydrogenperiodato)argentate(III) complex anion

Zhang, Jiong,Huo, Shuying,Shi, Hongmei,Shen, Shigang,Shang, Yanli

, p. 15 - 20 (2013)

The kinetics of oxidation of pyrrolidine by bis(hydrogenperiodato) argentate(III) complex anion ([Ag(HIO6)2]5-) was studied in alkaline medium, with reaction temperatures in the range of 15.0-30.0 C. The experiments indicated that the oxidation follows an overall second-order reaction, being first-order in both Ag(III) and pyrrolidine. The observed second-order rate constants, k′, decreased with increasing [IO4 -] but increased slightly with increasing [OH -]. The influence of ionic strength on the reaction rate was also investigated. The oxidation resulted in oxidative deamination of pyrrolidine, giving 4-hydroxybutyrate as the product. A reaction mechanism is proposed which includes an equilibrium between [Ag(HIO6)2]5- and [Ag(HIO6)2(OH)(H2O)]2-; these two Ag(III) species are reduced by pyrrolidine in parallel rate-determining steps. The rate equation derived from the proposed mechanism can explain the experimental observations. The rate constants of the rate-determining steps, together with the associated activation parameters, were calculated accordingly.

GAMMA-HYDROXYBUTYRATE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF DISORDERS

-

Paragraph 00222, (2018/10/19)

Provided herein are pharmaceutical compositions and formulations comprising mixed salts of gamma-hydroxybutyrate (GHB). Also provided herein are methods of making the pharmaceutical compositions and formulations, and methods of their use for the treatment of sleep disorders such as apnea, sleep time disturbances, narcolepsy, cataplexy, sleep paralysis, hypnagogic hallucination, sleep arousal, insomnia, and nocturnal myoclonus.

NEW PROCESS FOR THE PREPARATION OF NITROOXYDERIVATIVES OF PARACETAMOL

-

Page/Page column 6; 7, (2010/02/11)

The present invention relates to a new process for the preparation of a compound of the following formula (I).